Virginija Danylaité Karrenbauer

Publications
CV
Public outreach and news

Selected publications

Article: ACTA NEUROLOGICA SCANDINAVICA. 2022;145(5):599-609
Four Swedish cases of CSF1R-related leukoencephalopathy: Visualization of clinical phenotypes.
Rosenstein I; Andersen O; Victor D; Englund E; Granberg T; Hedberg-Oldfors C; Jood K; Fitrah YA; Ikeuchi T; Danylaité Karrenbauer V
Article: JOURNAL OF NEUROIMAGING. 2020;30(5):674-682
Machine Learning and Multiparametric Brain MRI to Differentiate Hereditary Diffuse Leukodystrophy with Spheroids from Multiple Sclerosis.
Mangeat G; Ouellette R; Wabartha M; De Leener B; Plattén M; Danylaité Karrenbauer V; Warntjes M; Stikov N; Mainero C; Cohen-Adad J; Granberg T
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):180
Plasma neurofilament light chain concentration is increased in anorexia nervosa.
Nilsson IAK; Millischer V; Karrenbauer VD; Juréus A; Salehi AM; Norring C; von Hausswolff-Juhlin Y; Schalling M; Blennow K; Bulik CM; Zetterberg H; Landén M
Article: MULTIPLE SCLEROSIS JOURNAL. 2019;25(1):104-112
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability.
Kavaliunas A; Danylaite Karrenbauer V; Gyllensten H; Manouchehrinia A; Glaser A; Olsson T; Alexanderson K; Hillert J
Article: MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL. 2019;5(1):2055217318822134
Cognitive function predicts work disability among multiple sclerosis patients.
Kavaliunas A; Tinghög P; Friberg E; Olsson T; Alexanderson K; Hillert J; Karrenbauer VD
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(4):817-822
Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
Granberg T; Hashim F; Andersen O; Sundal C; Karrenbauer VD
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2015;358(1-2):201-206
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Novakova L; Axelsson M; Malmeström C; Zetterberg H; Björkhem I; Karrenbauer VD; Lycke J
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2015;22(2):328-333
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Sundal C; Baker M; Karrenbauer V; Gustavsen M; Bedri S; Glaser A; Myhr K-M; Haugarvoll K; Zetterberg H; Harbo H; Kockum I; Hillert J; Wszolek Z; Rademakers R; Andersen O
Article: JOURNAL OF NEUROIMMUNOLOGY. 2014;274(1-2):149-154
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
Ferreira D; Voevodskaya O; Imrell K; Stawiarz L; Spulber G; Wahlund L-O; Hillert J; Westman E; Karrenbauer VD
Article: LANCET. 2008;372(9648):1463-1472
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Kappos L; Gold R; Miller DH; Macmanus DG; Havrdova E; Limmroth V; Polman CH; Schmierer K; Yousry TA; Yang M; Eraksoy M; Meluzinova E; Rektor I; Dawson KT; Sandrock AW; O'Neill GN; BG-12 Phase IIb Study Investigators

Articles

Article: FRONTIERS IN IMMUNOLOGY. 2025;16:1582789
Case report on severe myelin oligodendrocyte glycoprotein antibody-associated disease relapse after ectopic pregnancy and laparoscopic medical abortion: relevance of peripheral inflammation for demyelinating disease activity
Smertinaite L; Selin K; Vaitiniemi R; Balevicius R; Kollia E; Granberg T; Leite MI; Palace J; Blad H; Karrenbauer VD
Article: SCIENTIFIC REPORTS. 2025;15(1):3547
Working capacity level defines the specific impairment profile of the comprehensive ICF core set for multiple sclerosis
Valadkeviciene D; Zukauskaite I; Bileviciute-Ljungar I; Kizlaitiene R; Jatuzis D; Karrenbauer VD
Article: JOURNAL OF REHABILITATION MEDICINE. 2024;56:jrm19671
REVISION OF THE BRIEF INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH CORE SET FOR MULTIPLE SCLEROSIS: A STUDY OF THE COMPREHENSIVE ICF CORE SET FOR MULTIPLE SCLEROSIS WITH PARTICIPANTS REFERRED FOR WORK ABILITY ASSESSMENT
Valadkeviciene D; Jatuzis D; Zukauskaite I; Karrenbauer VD; Bileviciute-Ljungar I
Journal article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2023;455:121829
Does the brief ICF core set for multiple sclerosis needs to be modified?
Valadkeviciene D; Bileviciute-Ljungar I; Jatuzis D; Karrenbauer V; Zukauskaite I
Article: PATHOGENS. 2023;12(3):476
Syndrome of Transient Headache and Neurologic Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): HHV-7 Finding in Cerebrospinal Fluid Challenges Diagnostic Criteria
Sundholm A; Gustafsson R; Karrenbauer V
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2022;68:104393
Can fatigue predict the worsening of multiple sclerosis one year later? An explorative study with participants referred to assess their ability to work
Valadkeviciene D; Zukauskaite I; Karrenbauer VD; Bileviciute-Ljungar I
Article: SCIENTIFIC REPORTS. 2021;11(1):18528
Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
McKay KA; Wickstrom R; Hillert J; Karrenbauer VD
Article: SCIENTIFIC REPORTS. 2021;11(1):14987
Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study.
Karrenbauer VD; Bedri SK; Hillert J; Manouchehrinia A
Article: MULTIPLE SCLEROSIS JOURNAL. 2021;27(8):1240-1249
Accurate classification of secondary progression in multiple sclerosis using a decision tree
Ramanujam R; Zhu F; Fink K; Karrenbauer VD; Lorscheider J; Benkert P; Kingwell E; Tremlett H; Hillert J; Manouchehrinia A
Journal article: MOVEMENT DISORDERS. 2021;36(6):1470-1471
Chronic Immunosuppression and Potential Infection Risks in CSF1R-Related Leukoencephalopathy
Han J; Harris RA; Karrenbauer VD
Journal article: NEUROLOGY. 2021;96(15_supplement)
Altered numbers and volumes of secondary lysosomes in circulating monocytes in patient with CSF1R-related leukoencephalopathy (2257)
Mickeviciute GC; Smertinaite L; Han J; Ntzouni M; Guttmann P; Harris R; Sandell A; Mohseni S; Karrenbauer V
Journal article: NEUROLOGY. 2021;96(15_supplement)
Hereditary Diffuse Leukoencephalopathy with Spheroids caused by R777W and R782C mutations in CSF1R: A report of four cases in Sweden (2017)
Rosenstein I; Andersen O; Englund E; Granberg T; Jood K; Fitrah YA; Ikeuchi T; Karrenbauer V
Article: JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 2019;39(5):302-313
Different Interferon Beta Preparations Induce the Same Qualitative Immune Response in Human Skin
Hermanrud C; van Capel TMM; Auer M; Karrenbauer V; Deisenhammer F; de Jong EC; Fogdell-Hahn A
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(13):1782-1785
Similar familial risk in multiple sclerosis subgroups.
Song J; Karrenbauer V; Manouchehrinia A; Almqvist C; Hillert J; Westerlind H
Article: PLOS ONE. 2017;12(1):e0169460
Income in Multiple Sclerosis Patients with Different Disease Phenotypes
Kavaliunas A; Manouchehrinia A; Karrenbauer VD; Gyllensten H; Glaser A; Alexanderson K; Hillert J
Journal article: NEUROLOGY. 2015;84(14_supplement)
Hereditary diffuse leukoencephalopathy with spheroids: a volumetric comparison with multiple sclerosis and healthy controls (P4.050)
Granberg T; Andersen O; Sundal C; Danylaité Karrenbauer V
Journal article: NEUROLOGY. 2015;84(14_supplement)
National Swedish MS Register Based Study: the Symbol Digit Modalities Test as a predictor of work disability (P3.222)
Karrenbauer V; Brenner P; Hillert J; Tinghög P
Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(13):1727-1736
Interferon beta treatment of multiple sclerosis increases serum interleukin-7
Lundstrom W; Hermanrud C; Sjostrand M; Brauner S; Wahren-Herlenius M; Olsson T; Karrenbauer V; Hillert J; Fogdell-Hahn A
Journal article: NEUROLOGY. 2014;82(10_supplement)
CSF1R Gene Screening In A Cohort Of 218 Primary Progressive Multiple Sclerosis (PPMS) Patients From The Norwegian And Swedish National PPMS Registries (S34.009)
Sundal C; Baker M; Karrenbauer V; Myhr K-M; Haugarvoll K; Fujioka S; Harbo H; Aasly J; Hillert J; Wszolek Z; Rademakers R; Andersen O
Article: JOURNAL OF NEUROIMMUNOLOGY. 2013;254(1-2):170-173
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients
Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
Article: NEUROLOGY. 2011;77(16):1551-1560
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
Freedman MS; Bar-Or A; Oger J; Traboulsee A; Patry D; Young C; Olsson T; Li D; Hartung H-P; Krantz M; Ferenczi L; Verco T
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2008;264(1-2):9-17
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers:: Preliminary comparative PET studies with [¹¹C]vinpocetine and [¹¹C]PK11195 in patients
Vas A; Shchukin Y; Karrenbauer VD; Cselenyi Z; Kostulas K; Hillert J; Savic I; Takano A; Halldin C; Gulyas B
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2006;64(4):412-419
Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis
Liu G-Z; Gomes AC; Putheti P; Karrenbauer V; Kostulas K; Press R; Hillert J; Hjelmstrom P; Gao X-G
Article: CLINICAL NEUROLOGY AND NEUROSURGERY. 2006;108(5):456-460
Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis
Karrenbauer VD; Leoni V; Lim ET; Giovannoni G; Ingle GT; Sastre-Garriga J; Thompson AJ; Rashid W; Davies G; Miller DH; Bjorkhem I; Masterman T
Article: JOURNAL OF NEUROIMMUNOLOGY. 2005;167(1-2):210-214
Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis
Thangarajh M; Masterman T; Rot U; Duvefelt K; Brynedal B; Karrenbauer VD; Hillert J
Show more

All other publications

Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:790
Impact of COVID-19 infection on cognitive performance in MS patients at Karolinska University Hospital
Loowf I; Hillert J; Forsberg L; Karrenbauer VD
Meeting abstract: MULTIPLE SCLEROSIS JOURNAL. 2023;29:785-786
The effect of COVID-19 infection on physical disability progression in MS patients at Karolinska University Hospital
Tursunova K; Hillert J; Forsberg L; Karrenbauer VD
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):682-683
Prevalence and characteristics of MS patients with COVID-19 infection at Karolinska University Hospital, Stockholm, Sweden
Nygard L; Karrenbauer V; Forsberg L
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):1015
TOP20 Body Functions, Activities and Participation Categories Affecting Work Capacity Level of Multiple Sclerosis Patients: WHO Comprehensive ICF Core Set for Multiple Sclerosis Results
Valadkeviciene D; Zukauskaite I; Karrenbauer VD; Bileviciute-Ljungar I; Kizlaitiene R; Jatuzis D
Review: CELLULAR AND MOLECULAR LIFE SCIENCES. 2022;79(4):219
Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
Han J; Chitu V; Stanley ER; Wszolek ZK; Karrenbauer VD; Harris RA
Review: JOURNAL OF INTERNAL MEDICINE. 2022;291(3):269-282
Neuroimaging phenotypes of CSF1R-related leukoencephalopathy: Systematic review, meta-analysis, and imaging recommendations
Mickeviciute G-C; Valiuskyte M; Platten M; Wszolek ZK; Andersen O; Karrenbauer VD; Ineichen BV; Granberg T
Review: FRONTIERS IN NEUROLOGY. 2022;12:788168
Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development
Papapetropoulos S; Pontius A; Finger E; Karrenbauer V; Lynch DS; Brennan M; Zappia S; Koehler W; Schoels L; Hayer SN; Konno T; Ikeuchi T; Lund T; Orthmann-Murphy J; Eichler F; Wszolek ZK
Review: FRONTIERS IN NEUROLOGY. 2022;12:737211
Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function
Kavaliunas A; Danylaite Karrenbauer V; Binzer S; Hillert J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):269-270
Evaluation of Swedish National Board of Health and Welfare's quality care indicator M7 for multiple sclerosis - regular MRI examinations - at medical unit neuro, Karolinska University Hospital
Sandstrom E; Forsberg L; Mentesidou E; Hillert J; Karrenbauer VD
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):521
Swedish MS registry data improvement and evaluation study: Which CSF variable reflects best MRI activity in MS patients
Masood AA; Forsberg L; Mentesidou E; Hillert J; Karrenbauer VD
Preprint: RESEARCH SQUARE. 2021
CSF1R-Related Leukoencephalopathy Caused by CSF1R p.Arg777Trp and CSF1R p.Arg782Cys Mutations: A Report of Four Cases in Sweden
Rosenstein I; Andersen O; Daniel V; Englund E; Granberg T; Hedberg-Oldfors C; Jood K; Fitrah YA; Ikeuchi T; Karrenbauer VD
Preprint: RESEARCH SQUARE. 2021
Severe Neuroinflammatory Relapse after Extrauterine Pregnancy and Abortion: A Case Report on a Patient with Heterogenic MS Phenotype Carrying Myelin Oligodendrocyte Glycoprotein Autoantibodies
Selin K; Vaitiniemi R; Blad H; Karrenbauer VD
Review: ACTA NEUROLOGICA SCANDINAVICA. 2021;143(6):587-601
Socioeconomic consequences of multiple sclerosis-A systematic literature review
Kavaliunas A; Karrenbauer VD; Hillert J
Preprint: RESEARCH SQUARE. 2021
Severe Neuroinflammatory Relapse After Extrauterine Pregnancy and Abortion: A Case Report on a Patient With Heterogenic Ms Phenotype Carrying Myelin Oligodendrocyte Glycoprotein Autoantibodies
Kulmala K; Vaitiniemi R; Blad H; Karrenbauer VD
Conference publication: NEUROLOGY. 2021;96(15)
Altered numbers and volumes of secondary lysosomes in circulating monocytes in patient with CSF1R-related leukoencephalopathy
Mickeviciute GC; Smertinaite L; Han J; Ntzouni M; Guttmann P; Harris R; Sandell A; Mohseni S; Karrenbauer V
Conference publication: NEUROLOGY. 2021;96(15)
Hereditary Diffuse Leukoencephalopathy with Spheroids caused by R777W and R782C mutations in CSF1R: A report of four cases in Sweden
Rosenstein I; Andersen O; Englund E; Granberg T; Jood K; Fitrah YA; Ikeuchi T; Karrenbauer V
Preprint: RESEARCH SQUARE. 2021
Cerebrospinal Fluid Oligoclonal Immunoglobulin Gamma Bands and Long-term Disability Progression in Multiple Sclerosis: a Retrospective Cohort Study
Karrenbauer V; Bedri S; Hillert J; Manouchehrinia A
Preprint: RESEARCH SQUARE. 2021
Oligoclonal Immunoglobulin Gamma Bands and Long-Term Disability Progression in Multiple Sclerosis: A Retrospective Cohort Study
Karrenbauer VD; Bedri S; Hillert J; Manochehrinia A
Review: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2020;8(1):217
Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy
Han J; Sarlus H; Wszolek ZK; Karrenbauer VD; Harris RA
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):320-321
Performance on symbol digits modalities test preceding conversion to secondary progressive multiple sclerosis
Karrenbauer VD; Forsberg L; Hillert J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):655-656
Severe neuroinflammatory relapse after ectopic pregnancy termination: a case report on ms patient with myelin oligodendrocyte glycoproteinantibodies
Blad H; Kulmala K; Vaitiniemi R; Karrenbauer VD
Preprint: MEDRXIV. 2020
Accurate classification of secondary progression in multiple sclerosis
Ramanujam R; Zhu F; Fink K; Danylaitė Karrenbauer V; Lorscheider J; Benkert P; Kingwell E; Tremlett H; Hillert J; Manouchehrinia A; The BeAMS Study group
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:665-666
Comparison of cerebrospinal fluid biomarker profile in pediatric- versus adult-onset multiple sclerosis: a Swedish registry-based study
Karrenbauer VD; Manouchehrinia A; Hillert J; McKay K
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:994
Oligoclonal immunoglobulin gamma bands in the cerebrospinal fluid confers higher risk to reach EDSS milestones and to convert to secondary progression
Karrenbauer VD; Manouchehrinia A; Hillert J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:479-480
Cognitive function predicts work disability among multiple sclerosis patients
Kavaliunas A; Karrenbauer VD; Tinghog P; Friberg E; Olsson T; Alexanderson K; Hillert J
Conference publication: NEUROLOGY. 2017;88
Novel CSF biomarkers NFL and CXCL 13,-relationship with other CSF parameters and disease variables in MS
Evertsson B; Lofstrom V; Manouchehrinia A; Hillert J; Karrenbauer V
Conference publication: NEUROLOGY. 2017;88
Number of OCBs in CSF at diagnosis timepoint,-predictor of long term radiological outcome in MS?
Evertsson B; Karrenbauer V; Stawiarz L; Wahlund L-O; Hillert J; Westman E; Ferreira D
Review: ACTA NEUROLOGICA SCANDINAVICA. 2017;135(1):17-24
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
Vagberg M; Axelsson M; Birgander R; Burman J; Cananau C; Forslin Y; Granberg T; Gunnarsson M; von Heijne A; Jonsson L; Karrenbauer VD; Larsson E-M; Lindqvist T; Lycke J; Lonn L; Mentesidou E; Muller S; Nilsson P; Piehl F; Svenningsson A; Vrethem M; Wikstrom J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:586-587
Factors that changes carriership status of oligoclonal immunoglobulin gamma bands in cerebrospinal fluid in MS during follow up time, -registry based study
Karrenbauer VD; Hillert J; Manouchehrinia A
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:12-13
Income and cognitive impairment among multiple sclerosis patients.
Kavaliunas A; Karrenbauer VD; Gyllensten H; Manouchehrinia A; Glaser A; Alexanderson K; Hillert J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:460-461
Income among multiple sclerosis patients with different disease phenotypes
Kavaliunas A; Manouchehrinia A; Karrenbauer VD; Gyllensten H; Glaser A; Alexanderson K; Hillert J
Conference publication: NEUROLOGY. 2016;86
Oligoclonal Immunoglobulin Gamma Bands in the Cerebrospinal Fluid and Risk of Conversion to Secondary Progress in Multiple Sclerosis
Karrenbauer V; Hillert J; Manouchehrinia A
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23:192-193
CSF markers of inflammation and neurodegeneration in two Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS) families with diverging genotype and phenotype
Andersen O; Sundal C; Zetterberg H; Karrenbauer VD
Conference publication: NEUROLOGY. 2016;86
CSF Markers of Inflammation and Neurodegeneration in Two Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS) Families with Diverging Genotype and Phenotype
Karrenbauer V; Zetterberg H; Sundal C; Andersen O
Meeting abstract: JOURNAL OF NEUROIMMUNOLOGY. 2014;275(1-2):16-17
Number of OCBs in CSF at diagnosis timepoint,- predictor of long term radiological outcome in MS?
Karrenbauer VD; Evertsson B; Stawiarz L; Imrell K; Voevodskayac O; Wahlund L-O; Hillert J; Westman E; Ferreira D
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):299
Cerebrosterol levels in serum: does it reflect axonal damage in CNS?
Novakova L; Malmestrom C; Axelsson M; Masterman T; Bjorkhem I; Hillert J; Lycke J; Karrenbauer V
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2013;77(4):316
Elevated Plasma IL-7 Levels in Multiple Sclerosis Patients Treated with Interferon Beta are Caused by Decreased Cell Consumption
Hermanrud C; Lundstrom W; Sjostrand M; Brauner S; Wahren-Herlenius M; Olsson T; Karrenbauer VD; Hillert J; Fogdell-Hahn A
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2012;253(1-2):69-70
Interferon-beta therapy-induced elevation of serum IL-7 levels is blocked by anti-drug antibodies
Hermanrud C; Lundstrom W; Karrenbauer V; Hillert J; Fogdell-Hahn A
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2012;253(1-2):19
MS disease related variables and its impact on gray matter volume and cortical thickness
Karrenbauer VD
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2012;18:496-497
Plasma cerebrosterol measures predict cognitive processing speed deterioration 7 years later in MS patients
Stawiarz L; Bergendal G; Almkvist O; Fredrikson S; Link J; Leoni V; Bjorkhem I; Glaser A; Hillert J; Karrenbauer VD
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19:711
Cross-sectional study on relationship between Symbol Digit Modalities Test, plasma cerebrosterol concentration and MRI-based brain volumes of MS patients
Bergendal G; Stawiarz L; Almkvist O; Fredrikson S; Glaser A; Hillert J; Masterman T; Bjorkhem I; Leoni V; Karrenbauer VD
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19:352
Impact of OCB status and HLA-DRB1 risk alleles on lesion load in MS patients at age 40
Karrenbauer V; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
Doctoral thesis: 2012
Markers of inflammation and neurodegeneration in muliple sclerosis
Danylaité Karrenbauer V
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):200-201
Interferon-Beta Therapy-Induced Elevation of Serum IL-7 Levels is Blocked by Anti-Drug Antibodies
Hermanrud C; Lundstrom W; Karrenbauer V; Hillert J; Fogdell-Hahn A
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):207
Monogenetic Multiple Sclerosis or Spastic Paraplegia with Inflammation in a Consanguineous Family?
Imrell K; Karrenbauer V; Bomfim IL; Roshanisefat H; Lamb B; Hillert J; Kockum I; Masterman T
Conference publication: JOURNAL OF NEUROLOGY. 2011;258:154-155
Comparison of MRI lesion location in multiple sclerosis patients with and without oligoclonal bands in the cerebrospinal fluid
Karrenbauer VD; Prejs R; Imrell K; Glaser A; Masterman T; Hillert J
Show more

Employments

Affiliated to Research, Department of Clinical Neuroscience, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2012

Selected publications

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI